Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Terrie E. Inder
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Rapid whole-genome sequencing in pediatric neurology inpatients.
Kept as external metadata until matched
Genetic testing for diagnosing neurodevelopmental disorders and epilepsy: a systematic review and meta-analysis.
10.1186/s13643-025-02896-y · 2025
Genetic evaluation of the child with intellectual disability or global developmental delay: clinical report.
10.1542/peds.2025-072219 · 2025
Diagnostic yield of genome sequencing versus exome sequencing in pediatric patients with rare phenotypes: a systematic review and meta-analysis.
10.1002/ajmg.a.64146 · 2025
Molecular diagnostic yield of exome sequencing and genome sequencing in critical ill neonates and infants: a systematic review and meta-analysis.
10.1016/j.gim.2026.102627 · 2026
Evaluation of the feasibility, diagnostic yield, and clinical utility of rapid genome sequencing in infantile epilepsy (Gene-STEPS): an international, multicentre, pilot cohort study.
10.1016/s1474-4422(23)00246-6 · 2023
Project Baby Bear: rapid precision care incorporating rWGS in 5 California children’s hospitals demonstrates improved clinical outcomes and reduced costs of care.
10.1016/j.ajhg.2021.05.008 · 2021
‘It’s a nightmare’: informed consent in paediatric genome-wide sequencing. a qualitative expert interview study from Germany and Switzerland.
10.1038/s41431-023-01468-9 · 2023
Psychosocial effect of newborn genomic sequencing on families in the BabySeq Project: a randomized clinical trial.
10.1001/jamapediatrics.2021.2829 · 2021
Association of social determinants of health with genetic test request and completion rates in children with neurologic disorders.
10.1212/wnl.0000000000210275 · 2025
From genomic diagnosis to personalized RNA medicine: advances in next-generation sequencing and n-of-1 antisense oligonucleotide therapies for rare genetic diseases.
10.3390/genes17030318 · 2026
Individualized antisense oligonucleotides for SCN2A-related developmental epileptic encephalopathy.
10.1038/s41591-026-04527-y · 2026
No additional external references are available.